News
MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that an abstract highlighting pre-clinical data on DA-1241, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback